文献速递泌尿生殖腹部CTMRPET

上尿路尿路上皮癌的影像学表现

Imaging of Upper Tract Urothelial Carcinoma.
PubMed 文献 · Radiographics · 2024-01-01

上尿路尿路上皮癌起源于肾盂或输尿管,临床行为比下尿路尿路上皮癌更具侵袭性,需综合风险分层指导根治性肾输尿管切除术或保肾治疗。CT尿路造影是诊断和分期的首选方法,MR尿路造影因对小病灶敏感性差仅用于特殊临床场景,氟18氟脱氧葡萄糖PET有助于检出转移灶。

要点

  • 上尿路尿路上皮癌可表现为充盈缺损、管壁增厚和肿块样病变,CT尿路造影是诊断和分期的首选方法。
  • MR尿路造影对小病灶敏感性差,仅用于患者对碘对比剂有禁忌等特殊临床场景。
  • 治疗后需终身监测,因复发和异时性肿瘤发生率高;Lynch综合征常被漏诊,需特别关注。

核心结论

  • 上尿路尿路上皮癌影像表现多样,包括充盈缺损、管壁增厚和肿块样病变;CT尿路造影是诊断、分期或再分期的首选方法,影像学与内镜和病理检查共同参与风险分层,治疗后需终身监测。

研究设计与样本

  • 综述,纳入上尿路尿路上皮癌影像学相关文献,总结其影像表现、诊断与分期方法、鉴别诊断及临床管理要点,发表于Radiographics(©RSNA, 2024)。

关键影像表现/征象

  • 上尿路尿路上皮癌可表现为充盈缺损、管壁增厚和肿块样病变。
  • CT尿路造影是诊断和分期或再分期的首选方法,技术参数有多种变化。
  • 已努力优化图像质量和辐射暴露。
  • MR尿路造影因对小病灶敏感性差,仅用于特殊临床场景(如患者对碘对比剂有禁忌)。
  • 氟18氟脱氧葡萄糖PET有助于检出转移灶。

诊断标准与关键数值

  • CT尿路造影是上尿路尿路上皮癌诊断和分期或再分期的首选方法。
  • MR尿路造影对小病灶敏感性差,仅限用于特殊临床场景。
  • 氟18氟脱氧葡萄糖PET有助于检出转移病灶。
  • 图像引导活检可考虑用于性质不确定的病变。

临床应用与阅片要点

  • 放射科医生需熟悉上尿路尿路上皮癌的影像表现及其鉴别诊断。
  • 影像学与内镜和病理检查共同参与综合风险分层,以指导根治性肾输尿管切除术或保肾治疗决策。
  • 治疗后需终身监测,因复发和异时性肿瘤发生率高。
  • Lynch综合征是与上尿路尿路上皮癌相关的常被漏诊的遗传性疾病,在患者管理中需特别关注。
  • 图像引导活检可考虑用于性质不确定的病变。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Upper tract urothelial carcinoma (UTUC) originates in the renal pelvis or ureters and typically affects elderly patients, with its incidence increasing over the past few decades. UTUC is a distinct clinical entity with more aggressive clinical behavior than that of lower tract urothelial carcinoma. Due to the significant challenge of acquiring an adequate tissue sample for biopsy, comprehensive risk stratification is required for treatment planning, including radical nephroureterectomy and kidney-sparing management. Imaging plays an important integrated role in risk assessment along with endoscopy and pathologic examination. Lifelong surveillance is required after treatment due to the high incidence of recurrent and metachronous tumors. Lynch syndrome is a frequently unrecognized genetic disorder associated with UTUC that warrants specific attention in patient management. UTUC may manifest with diverse imaging findings, including filling defects, wall thickening, and mass-forming lesions. CT urography is the preferred modality for diagnosis and staging or restaging of UTUC, with numerous technical variations. Efforts have been made to optimize image quality and radiation exposure. Due to its poor sensitivity for small lesions, use of MR urography is limited to special clinical scenarios (eg, when patients have contraindications to iodinated contrast agents). Fluorine 18 fluorodeoxyglucose PET helps to detect metastatic lesions. Image-guided biopsy may be considered for uncertain lesions. Radiologists need to be familiar with the imaging findings and their differential diagnoses. ©RSNA, 2024 Supplemental material is available for this article.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Nakai H, Takahashi H, Wellnitz CV, et al. Imaging of Upper Tract Urothelial Carcinoma. Radiographics. 2024. PMID: 39480700. doi:10.1148/rg.240056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。